Free Trial

Pliant Therapeutics (PLRX) Competitors

$10.71
-0.49 (-4.38%)
(As of 06/18/2024 ET)

PLRX vs. ANNX, FGEN, MORF, AKRO, GLPG, XENE, PTCT, MOR, MLTX, and RYTM

Should you be buying Pliant Therapeutics stock or one of its competitors? The main competitors of Pliant Therapeutics include Annexon (ANNX), FibroGen (FGEN), Morphic (MORF), Akero Therapeutics (AKRO), Galapagos (GLPG), Xenon Pharmaceuticals (XENE), PTC Therapeutics (PTCT), MorphoSys (MOR), MoonLake Immunotherapeutics (MLTX), and Rhythm Pharmaceuticals (RYTM). These companies are all part of the "pharmaceutical preparations" industry.

Pliant Therapeutics vs.

Annexon (NASDAQ:ANNX) and Pliant Therapeutics (NASDAQ:PLRX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation.

Annexon currently has a consensus price target of $15.33, indicating a potential upside of 202.43%. Pliant Therapeutics has a consensus price target of $45.38, indicating a potential upside of 323.67%. Given Annexon's higher possible upside, analysts clearly believe Pliant Therapeutics is more favorable than Annexon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Annexon
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Pliant Therapeutics
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
3.00

Annexon has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500. Comparatively, Pliant Therapeutics has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500.

In the previous week, Pliant Therapeutics had 3 more articles in the media than Annexon. MarketBeat recorded 7 mentions for Pliant Therapeutics and 4 mentions for Annexon. Pliant Therapeutics' average media sentiment score of 0.88 beat Annexon's score of 0.62 indicating that Annexon is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Annexon
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Pliant Therapeutics
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Annexon's return on equity of -35.08% beat Pliant Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
AnnexonN/A -56.52% -46.50%
Pliant Therapeutics N/A -35.08%-31.78%

97.3% of Pliant Therapeutics shares are held by institutional investors. 12.7% of Annexon shares are held by insiders. Comparatively, 6.4% of Pliant Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Pliant Therapeutics received 18 more outperform votes than Annexon when rated by MarketBeat users. However, 74.60% of users gave Annexon an outperform vote while only 71.43% of users gave Pliant Therapeutics an outperform vote.

CompanyUnderperformOutperform
AnnexonOutperform Votes
47
74.60%
Underperform Votes
16
25.40%
Pliant TherapeuticsOutperform Votes
65
71.43%
Underperform Votes
26
28.57%

Annexon has higher earnings, but lower revenue than Pliant Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AnnexonN/AN/A-$134.24M-$1.47-3.45
Pliant Therapeutics$1.58M408.95-$161.34MN/AN/A

Summary

Pliant Therapeutics beats Annexon on 8 of the 13 factors compared between the two stocks.

Get Pliant Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PLRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PLRX vs. The Competition

MetricPliant TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$646.13M$6.94B$5.10B$8.47B
Dividend YieldN/A2.75%5.34%4.10%
P/E RatioN/A21.36178.3118.01
Price / Sales408.95240.522,280.0265.63
Price / CashN/A19.9131.3429.03
Price / Book1.355.714.844.26
Net Income-$161.34M$146.74M$109.50M$215.55M
7 Day Performance-8.93%-4.58%-3.56%-2.17%
1 Month Performance-29.86%-5.67%-4.74%-3.84%
1 Year Performance-51.89%-11.51%-2.80%0.39%

Pliant Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANNX
Annexon
3.0175 of 5 stars
$5.61
-6.7%
$15.33
+173.3%
+69.0%$518.42MN/A-3.8270
FGEN
FibroGen
4.054 of 5 stars
$1.13
-2.6%
$2.00
+77.0%
-93.8%$112.40M$147.75M-0.46486Positive News
MORF
Morphic
3.6395 of 5 stars
$26.42
-4.8%
$51.50
+94.9%
-55.3%$1.32B$520,000.00-7.55121Positive News
AKRO
Akero Therapeutics
4.0766 of 5 stars
$23.98
-2.6%
$41.13
+71.5%
-59.4%$1.66BN/A-7.4958Short Interest ↓
GLPG
Galapagos
0.6286 of 5 stars
$25.47
-1.0%
$34.50
+35.5%
-39.1%$1.68B$259.40M0.001,123
XENE
Xenon Pharmaceuticals
2.672 of 5 stars
$37.24
-2.1%
$59.11
+58.7%
-11.1%$2.81B$9.43M-13.74251Analyst Forecast
Positive News
PTCT
PTC Therapeutics
2.9206 of 5 stars
$35.81
-3.0%
$35.67
-0.4%
-17.2%$2.75B$937.82M-4.66988Positive News
MOR
MorphoSys
0.3876 of 5 stars
$18.13
-1.6%
$11.78
-35.0%
+134.7%$2.73B$257.89M-5.21524Positive News
MLTX
MoonLake Immunotherapeutics
1.197 of 5 stars
$41.40
-3.1%
$74.46
+79.9%
+51.4%$2.65BN/A-55.2050
RYTM
Rhythm Pharmaceuticals
3.2924 of 5 stars
$42.74
-3.7%
$54.33
+27.1%
+124.7%$2.61B$77.43M-9.23226Positive News

Related Companies and Tools

This page (NASDAQ:PLRX) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners